Skip to main content

Methocarbamol

NDC 63323-778 · Fresenius Kabi USA, LLC

Generic nameMethocarbamol
Dosage formINJECTION, SOLUTION
RouteINTRAMUSCULAR, INTRAVENOUS
Active ingredient(s)METHOCARBAMOL
Strength100 mg/mL
Pharmacologic classCentrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
Marketing categoryANDA

Packages

63323-778-10 — 25 VIAL in 1 CARTON (63323-778-10) / 10 mL in 1 VIAL (63323-778-21)

Billed under HCPCS

J2800 — Injection, methocarbamol, up to 10 ml Medicare Part B payment limit (ASP + 6%): $3.84

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

60760-725 — methocarbamol, 60760-770 — Methocarbamol Tablets, 60760-875 — Methocarbamol, 61919-368 — METHOCARBAMOL, 61919-616 — Methocarbamol, 62207-754 — Methocarbamol Tablets, 62207-770 — Methocarbamol Tablets, 63187-019 — Methocarbamol, 63187-087 — Methocarbamol, 63187-130 — Methocarbamol, 63561-0173 — Methocarbamol, 63561-0174 — Methocarbamol, 63629-1123 — Methocarbamol, 63629-1622 — Methocarbamol, 63629-2418 — methocarbamol, 63629-2419 — methocarbamol, 63629-2420 — methocarbamol, 63629-4882 — methocarbamol, 63629-8995 — Methocarbamol, 63629-9288 — methocarbamol, +188 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources